Banco Santander’s Apyx Medical APYX Stock Holding History

Banco Santander’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-125,000	Closed	-$561K	–	361
2022 Q3	$561K	Hold	125,000	–	–	0.01%	289
2022 Q2	$733K	Hold	125,000	–	–	0.01%	303
2022 Q1	$816K	Buy	+125,000	New	+$1.23M	0.01%	324

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Banco Santander's APYX Position: Q4 2022 in Review

Banco Santander sold out of Apyx Medical (APYX) in Q4 2022, closing a stake of 125,000 shares — an estimated $561K sold.

Banco Santander first reported a position in APYX in Q1 2022 and held it in 3 quarters. The position peaked at $816K in Q1 2022. 50 funds tracked by Wall St. Rank hold APYX as of Q4 2022.

Banco Santander reported no remaining Apyx Medical position as of Q4 2022 after selling out during the quarter.
Banco Santander sold 125,000 Apyx Medical shares in Q4 2022, an estimated $561K.
Banco Santander first reported a position in Apyx Medical in Q1 2022 and held it in 3 quarters.
Banco Santander's Apyx Medical position peaked at $816K in Q1 2022.
50 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2022.

Based on Banco Santander's 13F filing for Q4 2022, filed 13 Feb 2023.